Companies ›Healthcare ›LAXD.NS

LAXD.NS — NSE (India) Medical Equipment, Supplies & Distribution

Laxd.Ns

$204,03

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

14,2 %

ROE

15,2 %

Net margin

13,3 %

Debt / equity

0,09

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

LAXD.NS operates in the Medical Equipment, Supplies & Distribution industry, providing healthcare services and equipment to its customers.

Business. LAXD.NS operates in the Medical Equipment, Supplies & Distribution industry, providing healthcare services and equipment to its customers.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryMedical Equipment, Supplies & Distribution

ActivityHealthcare Services & Equipment

Generated · model-assisted

Sell-side consensus

BUY3 analysts

3 buy0 hold0 sell

Avg 12m price target316,67

Analyst recommendations

3 analysts · consensus Buy

Buy3

Hold0

Sell0

12-month price target

316,67

Consensus of sell-side coverage.

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts→

Buy

3 analysts · indicative

Ownership

—

not yet wired

Profitability→

15,2 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning LAXD.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to LAXD.NS. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

LAXD.NS operates in the Medical Equipment, Supplies & Distribution industry, providing healthcare services and equipment to its customers.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryMedical Equipment, Supplies & Distribution

ActivityHealthcare Services & Equipment

AI synthesis

GENERATED

LAXD.NS maintains a strong liquidity position, with a current ratio of 3.3 and cash and equivalents amounting to INR 610.93 million, which is significantly higher than the typical liquidity requirements for its industry. The company's debt-to-equity ratio is 0.09, indicating a conservative capital structure with minimal reliance on debt financing.

The company's profitability is robust, with a return on equity (ROE) of 15.24% and a return on assets (ROA) of 11.16%. These figures are well above the industry median for ROE and ROA, suggesting that LAXD.NS is effectively utilizing its equity and assets to generate returns.

LAXD.NS's revenue is primarily concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification. The company's revenue concentration in a single business segment may expose it to higher operational and market risks if demand for healthcare services and equipment declines.

The company's growth trajectory is positive, with a strong operating cash flow of INR 438.32 million and a free cash flow of INR 243.13 million. These figures indicate that LAXD.NS is generating sufficient cash to support its operations and potentially fund future growth initiatives.

LAXD.NS has a low risk of dilution, with no immediate filing-based liquidity or dilution flags detected. The company's conservative capital structure and strong liquidity position reduce the likelihood of near-term equity dilution.

Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's strong buy recommendation from analysts and the positive price targets suggest that the market has a favorable outlook on LAXD.NS.

Key takeaways

LAXD.NS has a strong liquidity position with a current ratio of 3.3 and significant cash reserves.
The company's profitability is robust, with ROE and ROA well above industry medians.
LAXD.NS's revenue is concentrated in a single business segment, which may increase operational risk.
The company's growth is supported by strong operating and free cash flows.
LAXD.NS has a low risk of dilution and a favorable analyst outlook.

Bull / Bear case

analysis pipeline

— missing data

In focus — financials by report

Valuation

Market price

$204,03

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$2.09B

Net cashⓘ

$415.8M

Current ratioⓘ

3.3

Debt / equityⓘ

0.1

ROAⓘ

11.2%

ROEⓘ

15.2%

Cash conversionⓘ

138.0%

CapEx / revenueⓘ

-6.7%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Next quarternear-term

Earnings · next quarterconf 45 %

EPS

Consensus EPS

5,70

Predicted surprise

+0,00

Beat probability

45 %

Analysts

Other metrics

Revenue

—

no estimate

Segment revenue

—

no estimate

Margin

—

no estimate

Segment margin

—

no estimate

as of 2026-05-10 · Earnings Surprise V1

Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.

Full fiscal year~1 year ahead

Full fiscal year · our forecast vs guidance vs consensus

Metric	Our forecast	Guidance	Consensus
EPS	—no estimate	—no estimate	5,70
Revenue	—no estimate	—no estimate	2,8B INR
Operating income	—no estimate	—no estimate	260,5M INR

Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.

Probabilistic model output — not investment advice. · generated 2026-08-04

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Consensus distribution

sell-side coverage

Recommendation distribution3 analysts

Strong buy2

Buy1

Hold0

Sell0

Strong sell0

12-month price target$316,67 · Median $290,00

Low $260,00High $400,00

Operating income · consensus260,5M INR

EPS surprise

−17,4 %

reported vs consensus · miss

Revenue surprise

−13,4 %

reported vs consensus · miss

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

Low$260,00

Mean$316,67

Median$290,00

High$400,00

Spot$204,03

+55.2 %implied to mean12-month sell-side price targets · ▲ spot

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskLow

Filing-based flags

No immediate filing-based liquidity or dilution flags were detected.

Benchmarks vs cohort

Op Margin14,2 %Above median

Net Margin13,3 %Above P75

ROE15,2 %Best in class

Capex / Rev-6,7 %Below median

D/E0,09Above median

Cash Conv1,38Above median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

LAXD.NS Market data — financials · 2026-05-28
Laxmi Dental Ltd Market data — analyst estimates · 2026-05-28

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

LAXD.NSCanonical

NSE (India) · USD

Intel & risk

PredictorBeat prob45 %Surprise+0,00Full forecast →

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskLow

No immediate filing-based liquidity or dilution flags were detected.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

Analyst recommendations

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Consensus distribution

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread